2024 TM Society Meeting
Archives for PosterPublications & Posters
VIEW:
The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.
World Glaucoma Congress 2023
Investigator-initiated study to assess the safety, tolerability, and ocular hypotensive efficacy of QLS-111
Association for Research in Vision and Ophthalmology
QLS-101 In Vivo Systemic and Ocular Toxicology and Pharmacokinetic Profiles
Association for Research in Vision and Ophthalmology
QLS-101 In Vitro Ocular Tissue Conversion and Activity Profile
American Glaucoma Society